References

  1. Tamiflu® (oseltamivir phosphate) Prescribing Information. South San Francisco, CA: Genentech USA, Inc.; December 2012.
  2. Centers for Disease Control and Prevention. Seasonal influenza. http://www.cdc.gov/flu/about/qa/disease.htm. Accessed July 6, 2012.
  3. Centers for Disease Control and Prevention. The influenza (flu) viruses. http://www.cdc.gov/flu/about/viruses/index.htm. Accessed July 22, 2010.
  4. Centers for Disease Control and Prevention. Flu symptoms & severity. http://www.cdc.gov/flu/about/disease/symptoms.htm. Accessed July 22, 2010.
  5. Centers for Disease Control and Prevention. People at high risk of developing flu-related complications. http://www.cdc.gov/flu/about/disease/high_risk.htm. Accessed July 22, 2010.
  6. Centers for Disease Control and Prevention. Updated CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009-April 10, 2010. http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm. Accessed July 22, 2010.
  7. Centers for Disease Control and Prevention. Flu View. 2008-2009 influenza season week 12 ending March 28, 2009. http://www.cdc.gov/flu/weekly/weeklyarchives2008-2009/weekly12.htm. Accessed July 22, 2010.
  8. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001;20:127-133.
  9. Poehling KA, Edwards KM, Weinberg GA, et al; New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355:31-40.
  10. Centers for Disease Control and Prevention. Role of laboratory diagnosis of influenza. http://www.cdc.gov/flu/professionals/diagnosis/labrole.htm. Accessed July 22, 2010.
  11. Centers for Disease Control and Prevention. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage — United States, October - December 2009. MMWR Morb Mortal Wkly Rep. January 22, 2010; 59:44 - 48.
  12. Centers for Disease Control and Prevention. ACIP recommendations: introduction and biology of influenza. http://www.cdc.gov/flu/professionals/acip/background.htm. Accessed July 22, 2010.
  13. Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. http://www.cdc.gov/h1n1flu/recommendations.htm. Accessed June 28, 2012.
  14. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA. 2000;283:1016-1024.
  15. Data on file, Genentech USA, Inc.
  16. Jain S, Kamimoto L, Bramley AM, et al; 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361:1935-1944.
  17. National Institute of Allergy and Infectious Diseases. Is it a cold or the flu? http://www.niaid.nih.gov/topics/Flu/Documents/sick.pdf. Accessed August 3, 2010.
  18. Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 11th ed. Washington, DC: Public Health Foundation; 2009:135-154. http://www.cdc.gov/vaccines/pubs/pinkbook/default.htm. Accessed June 25, 2010.
  19. Centers for Disease Control and Prevention. Flu View. 2008-2009 influenza season week 35 ending September 5, 2009. http://www.cdc.gov/flu/weekly/weeklyarchives2008-2009/weekly35.htm. Accessed July 22, 2010.
  20. Centers for Disease Control and Prevention. Flu View. 2009-2010 influenza season week 20 ending May 22, 2010. http://www.cdc.gov/flu/weekly/weeklyarchives2009-2010/weekly20.htm. Accessed June 24, 2010.
  21. Centers for Disease Control and Prevention. Rapid diagnostic testing for influenza. Information for health care professionals. http://cdc.gov/flu/professionals/diagnosis/rapidclin.htm.
  22. Welliver R, Monto A, Carewicz O, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 2001;285(6):748-754.
  23. Hayden FG, Belshe R, Villanueva C, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis. 2004;189:440-449.
  24. Centers for Disease Control and Prevention. Vaccine selection for the 2011-2012 and 2012-2013 influenza seasons: questions & answers. http://www.cdc.gov/flu/about/qa/vaccine-selection.htm. Accessed June 28, 2012.
  25. Centers for Disease Control and Prevention. FluView 2011-2012 influenza season week 20 ending May 19, 2012, http://www.cdc.gov/flu/weekly/weeklyarchives2011-2012/weekly20.htm. Accessed June 28, 2012.
  26. Centers for Disease Control and Prevention. Estimates of deaths associated with seasonal influenza — United States, 1976-2007. www.cdc.gov/mmwr/preview/mmwrhtml/mm5933a1.htm. Accessed June 14, 2012.
  27. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. August 6, 2010;59(rr08):1-62.
  28. Centers for Disease Control and Prevention. Questions & Answers: seasonal influenza associated hospitalizations in the United States. www.cdc.gov/flu/about/qa/hospital.htm. Accessed July 19, 2011.
  29. World Health Organization Writing Group. Nonpharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis. 2006;12:81-87.
  30. Centers for Disease Control and Prevention. Protecting against influenza (flu): advice for caregivers of children less than 6 months old. www.cdc.gov/flu/protect/infantcare.htm. Accessed July 19, 2011.
  31. Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. January 21, 2011;60(RR01):1-26.
  32. Centers for Disease Control and Prevention. 2010-2011 influenza antiviral medications: summary for clinicians. www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm. Accessed July 19, 2011.
  33. American Academy of Pediatrics. Policy Statement — Recommendations for Prevention and Control of Influenza in Children, 2011-2012. Committee on Infectious Diseases. Pediatrics; originally published online September 2, 2011. http://pediatrics.aapublications.org/content/early/2011/08/30/peds.2011-2295. Accessed September 7, 2011.
  34. Centers for Disease Control and Prevention. Interim estimates of cumulative influenza vaccination coverage for 2010-11 season — United States, end of February 2011. http://www.cdc.gov/flu/professionals/vaccination/reporti1011/reportII/. Accessed July 19, 2011.
  35. RAND Health. Seasonal flu vaccination: why don’t more Americans get it? http://www.rand.org/pubs/research_briefs/RB9572.html. Accessed July 19, 2011.
  36. US Census Bureau. USPOP Clock Projection. 2011. http://www.census.gov/population/www/popclockus.html. Accessed June 20, 2012.
  37. Fiore AE, Fry A, Shay D, Gubareva L, Bresse JS, Uyeki TM; Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(RR01):1-24. http://www.cdc.gov/h1n1flu/recommendations.htm. Accessed June 28, 2012.
  38. Centers for Disease Control and Prevention. CDC recommendations for influenza antiviral medications remain unchanged. http://www.cdc.gov/media/haveyouheard/stories/influenza_antiviral.html. Accessed June 4, 2012.

SAFETY FIRST

Roll over to read the Important Safety Information ›

There's No Such Thing As A Little Flu

Sign Up for Flu Alerts

Stay ahead of the flu.

Flu Alert
example

See larger ›

Flu Alert example

Indications

Tamiflu is a prescription medicine used to treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than 2 days. Tamiflu can also reduce the chance of getting the flu in people 1 year and older. Tamiflu is not a substitute for an annual flu vaccination.

Important Safety Information

Before taking Tamiflu, tell your doctor if you are pregnant or nursing. Let your doctor know if you have kidney disease, heart disease, respiratory disease, or other serious health conditions. Also tell your doctor about any medications you are taking or if you've received a nasal-spray flu vaccine in the past 2 weeks. If you have an allergic reaction or a severe rash with Tamiflu, stop taking it, and contact your doctor right away. This may be very serious. The most common side effects of Tamiflu are mild to moderate nausea and vomiting.

People with the flu, particularly children and adolescents, may be at increased risk for seizures, confusion, or abnormal behavior when they first get sick. These events may occur when the flu is not treated or right after starting Tamiflu. These events are uncommon but may lead to accidental injury. Contact a healthcare professional right away if you notice any unusual behavior.

The most common side effects are mild to moderate nausea and vomiting.

Please see the Tamiflu full Prescribing Information for complete safety information.